Immuno-oncology specialist Immunocore plc announced the completion of a $75m Series C private financing round.

Muttenz-based Clariant announced the appointment of Conrad Keijzer as new Chief Executive Officer,

Following a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2.

Italian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement.

University of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results. 

Dear readers,

We wish all visitors to our news page a peaceful and healthy New Year and a successful start to the New Year.  Stay healthy! We will be back with the latest news from 4 January.

Best regards

Your editorial team of European Biotechnology Magazine

Following a rapid FDA approval, the European drug authority EMA has recommended to conditionally  approve BioNTech’s mRNA vaccine BNT162b2 in the EU.

Only two and a half months after its launch, the EU bioecocomy venture capital fund ECBF has doubled the volume of its first closing.

Danish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies.

Strasbourg-based Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer.